Instrument Fundamentals
| Date | Close | Change | Change (%) | Open | High | Low |
|---|
News
13,487 Merck & Co., Inc. $MRK Shares Sold by Generali Investments Management Co LLC
Best Healthcare Stocks To Keep An Eye On - October 18th - Stock Observer
Merck & Co., Inc. $MRK Stock: Birch Hill Investment Advisors LLC Cuts Holdings
Merck & Co., Inc. $MRK Stock: 1834 Investment Advisors Co. Decreases Position
Kintegral Advisory LLC Buys New Holdings in Moderna, Inc. $MRNA - Stock Observer
Healthcare Stocks To Consider - October 17th - Markets Daily
Merck & Co., Inc. $MRK Stock: Hengehold Capital Management LLC Reduces Position
TD Waterhouse Canada Inc. Purchases 131,302 Shares of Merck & Co., Inc. $MRK
4,916 Merck & Co., Inc. $MRK Shares Sold by Cyndeo Wealth Partners LLC - Zolmax
Merck & Co., Inc. $MRK Shares Sold by Cantor Fitzgerald Investment Advisors L.P. - Markets Daily
Merck & Co., Inc. $MRK Stock: Cantor Fitzgerald Investment Advisors L.P. Cuts Position
Merck & Co., Inc. $MRK Shares Sold by Cyndeo Wealth Partners LLC - Daily Political
Merck & Co., Inc. $MRK Stock: Banque Pictet & Cie SA Cuts Holdings
RBC Capital Sticks to Its Buy Rating for Roche Holding AG (RHHVF)
Eli Lilly & Co (LLY) Receives a Buy from RBC Capital
RBC Capital Sticks to Their Hold Rating for Merck & Company (MRK)
RBC Capital Reaffirms Their Hold Rating on Pfizer (PFE)
AbbVie vs. Merck: Which Pharma Stock Offers Better Value?
Insider Selling: Moderna (NASDAQ:MRNA) President Sells $8,640,084.40 in Stock - Stock Observer
Merck's Rally Reflects Renewed Confidence, but Has the Market Priced in Too Much? - Insider Monkey
Healthcare Stocks To Add to Your Watchlist - October 16th - Stock Observer
Milestone Asset Management LLC Sells 9,248 Shares of Merck & Co., Inc. $MRK
NFSG Corp Buys 4,100 Shares of Merck & Co., Inc. $MRK - Markets Daily
NFSG Corp Purchases 5,162 Shares of Moderna, Inc. $MRNA - Markets Daily
8,527 Shares of Merck & Co., Inc. $MRK Acquired by Neumann Capital Management LLC
18,326 Merck & Co., Inc. $MRK Shares Sold by Ninety One UK Ltd
Merck & Co., Inc. $MRK Stock: State of Alaska Department of Revenue Reduces Stake
Merck & Co., Inc. $MRK Stock Sold by Community Trust & Investment Co. - Zolmax
1,133,024 Merck & Co., Inc. $MRK Shares Sold by Assenagon Asset Management S.A.
Moderna, Inc. $MRNA Position Lifted by NFSG Corp - Stock Observer
8,294 Merck & Co., Inc. $MRK Shares Sold by State of Alaska Department of Revenue - Daily Political
Reviewing ABVC BioPharma (NASDAQ:ABVC) & Merck & Co., Inc. (NYSE:MRK) - Daily Political
Moderna (NASDAQ:MRNA) Shares Up 4.5% Following Analyst Upgrade
PFG Private Wealth Management LLC Makes New Investment in Moderna, Inc. $MRNA - Zolmax
Pharmaceutical Stocks To Keep An Eye On - October 15th - Zolmax
Merck & Co., Inc. (MRK) Reports Promising Skin Cancer Trial Results for Keytruda and Personalized mRNA Vaccine
VMS Asset Management Limited Makes New Investment in Merck & Co., Inc. $MRK
Merck & Co., Inc. $MRK Stock Position Lessened by HBW Advisory Services LLC
Merck & Co., Inc. $MRK Stock: Fort Washington Investment Advisors Inc. OH Decreases Holdings
Merck & Co., Inc. $MRK Shares Bought by Strategy Asset Managers LLC - Markets Daily
Western Financial Corp CA Acquires 29,043 Shares of Merck & Co., Inc. $MRK
Merck & Co., Inc. $MRK Shares Sold by Godsey & Gibb Inc.
Merck & Co., Inc. $MRK Stock: Cliftonlarsonallen Wealth Advisors LLC Cuts Holdings
Merck & Co., Inc. $MRK Holdings Lessened by Fort Washington Investment Advisors Inc. OH - Daily Political
Merck & Co., Inc. $MRK Stock Acquired by Strategy Asset Managers LLC - Stock Observer
Merck & Co., Inc. (NYSE:MRK) Price Target Raised to $145.00 - Stock Observer
Small Cell Lung Cancer Clinical Trial Drug Development Pipeline Expands with Contributions from 100+ Key Companies | DelveInsight | ABNewswire
Endometrial Cancer Market Poised for Sustained Growth Amid Advancements in Treatment and Clinical Innovation - DelveInsight | AstraZeneca, Karyopharm Therapeutics, Evergreen Therapeutics, Abbott | ABNewswire
Sanders Morris Harris LLC Purchases 6,296 Shares of Merck & Co., Inc. $MRK
Erste Group Bank Has Bearish Outlook for MRK FY2026 Earnings - Daily Political
Merck & Co., Inc. (NYSE:MRK) Stock Jumps 3.6% - Still a Buy?
Top Healthcare Stocks To Research - October 14th - Stock Observer
10,339 Merck & Co., Inc. $MRK Shares Acquired by First Citizens Bank & Trust Co.
Merck & Co., Inc. $MRK Holdings Increased by First Citizens Bank & Trust Co.
Merck & Co., Inc. $MRK Stock Holdings Cut by Salem Investment Counselors Inc.
Merck & Co., Inc. $MRK Position Cut by Perpetual Ltd
Promising Pharmaceutical Stocks To Follow Now - October 11th - Markets Daily
Promising Healthcare Stocks To Keep An Eye On - October 11th - Stock Observer
Merck & Co., Inc. $MRK Stock Holdings Lowered by Courier Capital LLC - Zolmax
48,205 Merck & Co., Inc. $MRK Shares Sold by Courier Capital LLC
Analyzing Merck & Co., Inc. (NYSE:MRK) & Karyopharm Therapeutics (NASDAQ:KPTI) - Stock Observer
Merck (MRK) Reports a Negative Operating Margin and Pays Out 266% of Earnings. What Explains Both?
Merck & Co., Inc. $MRK Shares Bought by Sax Wealth Advisors LLC
9,102 Merck & Co., Inc. $MRK Shares Acquired by Fragasso Financial Advisors Inc
Erste Group Bank Has Pessimistic View of MRK FY2026 Earnings - Zolmax
Merck & Co., Inc. $MRK Position Increased by NorthCrest Asset Manangement LLC
Merck & Co., Inc. (NYSE:MRK) Stock Has Consensus Target Price of $146.36 According to Brokerages - Zolmax
Promising Healthcare Stocks To Keep An Eye On - October 11th - Zolmax
Merck & Co., Inc. (NYSE:MRK) Stock Price Target Raised at Citigroup - Markets Daily
Citigroup Forecasts Strong Price Appreciation for Merck & Co., Inc. (NYSE:MRK) Stock - Stock Observer
Merck DME trispecific in shade of anti-VEGF, safety issue confirmed
Merck & Co., Inc. (NYSE:MRK) Stock Price Target Cut by Royal Bank Of Canada
NSCLC Pipeline 2026: FDA Approvals and Clinical Trials Landscape with MOA and ROA Highlights by DelveInsight | AbbVie, Xcovery, Sanofi, Pfizer, Mirati Therapeutics, AstraZeneca, Daiichi Sankyo, Merck | ABNewswire
Promising Pharmaceutical Stocks To Follow Now - October 11th - Daily Political
Promising Healthcare Stocks To Follow Today - October 10th - Zolmax
Merck & Co., Inc. $MRK Shares Sold by Castle Rock Wealth Management LLC
Contrasting Merck & Co., Inc. (NYSE:MRK) and CervoMed (NASDAQ:CRVO) - Daily Political
11,142 Merck & Co., Inc. $MRK Shares Bought by Wedmont Private Capital
Merck & Co., Inc. $MRK Shares Sold by Brown Shipley& Co Ltd - Daily Political
Merck & Co., Inc. $MRK Position Raised by Mn Services Vermogensbeheer B.V.
Farther Finance Advisors LLC Acquires 11,956 Shares of Merck & Co., Inc. $MRK
Rep. Maria Elvira Salazar Sells Off Shares of Merck & Co., Inc. (NYSE:MRK)
10,500 Merck & Co., Inc. $MRK Shares Bought by Mn Services Vermogensbeheer B.V. - Daily Political
Quintet Private Bank Europe S.A. Grows Stock Position in Merck & Co., Inc. $MRK
Canadians Encouraged to Go Beyond the Finish Line for Their Health This Fall
Halozyme Wins Dutch Patent Case Against Merck Over Keytruda SC
Merck & Co., Inc. $MRK Shares Bought by Congress Asset Management Co.
Merck & Co., Inc. (NYSE:MRK) Price Target Raised to $165.00 - Zolmax
Combined limbal dysmaturation and microcyst like epithelial changes with corneal nerve alterations of a novel anti nectin-4-MMAE antibody drug conjugate
11,515 Shares of Merck & Co., Inc. $MRK Acquired by Canandaigua National Trust Co of Florida - Daily Political
Merck & Co., Inc. $MRK Stock Position Cut by Canandaigua National Bank & Trust Co. - Daily Political
Merck & Co., Inc. (NYSE:MRK) Stock Price Target Lowered at Morgan Stanley
MerckCo News
CoreWeave Stock Forecast 2026–2030: Can CRWV Recover From the AI Debt Sell-Off?
Nebius Stock Price Prediction 2026–2030: Can AI Cloud Growth Justify the Cost?
Eli Lilly Stock Forecast 2026–2030: Can LLY Break Above $1,300 After Its 7% Five-Session Rally?
Is Tesla Stock a Good Buy Right Now? Earnings, AI Growth and Valuation Risks
Latest news
Show more
USD/JPY Holds Near 158 as Intervention Risk Caps Gains and Fed Hike Bets Ease
Meta Earnings Preview: Can AI Growth Restore Confidence After the Nasdaq Sell-Off?
Nasdaq Falls 4.48% as AI Debt Concerns Shake Tech Stocks; US Futures Rebound
Gold Price Forecast This Week: Can XAU/USD Reclaim $4,200 as Fed Rate-Hike Risks Persist?
Tesla Earnings Preview: Can Strong Deliveries Offset Rising Robotaxi and AI Costs?
